SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is seeing intense volatility driven by a technical short squeeze and heavy concentration of ownership, prompting heated debates among traders over whether the surge is a sustainable momentum play or a manipulated trap. The community is actively tracking institutional filings and options flow while warning of the high-risk, exit-liquidity nature of the current price action.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors react to a significant expansion of its partnership with NVIDIA, which integrates QNX technology into AI-driven robotics and industrial systems. The community is actively debating the stock's transition from a legacy brand to a critical infrastructure provider, fueled by high volume and bullish sentiment surrounding its growing role in physical AI.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is trending as investors aggressively discuss persistent rumors of a potential buyout, fueled by recent hiring activity and comparisons to successful acquisitions within the biotech sector. The community is actively debating the stock's price action and institutional accumulation, with many expressing frustration over the lack of official news despite strong long-term growth prospects.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending due to significant institutional interest and anticipation surrounding its role in the unfolding AI infrastructure supercycle, as investors weigh its potential to compete with major semiconductor peers. The community is actively debating the stock's recent price appreciation, with bulls pointing to strong CPU and GPU demand, while others caution against overstretched valuations following a prolonged period of positive momentum.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is surging on heavy volume as investors react to a significant multi-year contract with the Department of War and growing anticipation around the company's deepening ties to key aerospace and defense players. The community is actively debating the stock's massive short interest and potential for a squeeze against concerns over future capital raises and dilution, while bulls highlight the critical nature of its additive manufacturing technology for mission-ready defense production.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is experiencing significant market volatility and attention as traders debate its long-term potential in AI power infrastructure versus its high valuation and ongoing losses. The community is actively tracking technical breakout patterns, institutional buying, and speculation about potential partnerships, while simultaneously clashing over whether the stock's current trajectory represents a sustained growth phase or an overextended speculative pump.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp is trending heavily as investors react to a newly announced 100 million dollar share repurchase program, which has fueled widespread optimism about the company's financial health and short-squeeze potential. The community is actively debating the stock's long-term valuation relative to sector peers, with many bulls viewing the buyback and recent regulatory changes regarding day trading rules as key catalysts for a significant price re-rating.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

American Airlines is trending as investors grapple with the airline's significant debt load, rising jet fuel costs, and recent volatility sparked by merger rumors and regional geopolitical instability. The community is actively debating the stock's long-term viability, with many closely tracking updates on potential conflict-related supply disruptions and the company's ability to manage fuel-intensive operations.

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Dexcom Inc

Dexcom is currently facing intense volatility as traders debate the company's future following reports of institutional selling and ongoing concerns regarding product manufacturing and recent management changes. The community is heavily split, with some investors betting on a significant rebound fueled by potential institutional buybacks or positive upcoming catalysts, while others are aggressively shorting the stock, citing ongoing lawsuits and perceived product shortcomings.

Groupon, Inc. engages in the global scaled two-sided marketplace that connects consumers to merchants. It operates through the North America and International geographical segments. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell in October 2008 and is headquartered in Chicago, IL.

Groupon Inc

Groupon is experiencing significant volatility and trading momentum, driven by high short interest and social media chatter surrounding a potential short squeeze. Investors are debating its long-term viability, with bulls pointing to a turnaround strategy and institutional accumulation, while bears continue to highlight weak fundamentals and the perception that the price action is heavily manipulated.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eight ratings firms that are currently covering the firm...

LENZ Therapeutics (NASDAQ:LENZ) Price Target Cut to $48.00 by Analysts at HC Wainwright

HC Wainwright reduced their target price on LENZ Therapeutics from $56.00 to $48.00 and set a "buy" rating on the stock in a report on Tuesday...

Aberdeen Group plc Increases Holdings in LENZ Therapeutics, Inc. $LENZ

Aberdeen Group plc lifted its position in shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) by 274.4% during the fourth quarter, according to the company in its most recent filing with...

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) have earned an average rating of "Moderate Buy" from the eight brokerages that are covering the stock, MarketBeat.com reports. One...

HC Wainwright Issues Positive Forecast for LENZ Earnings

LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) - Investment analysts at HC Wainwright increased their Q1 2026 earnings per share (EPS) estimates for LENZ Therapeutics in a report issued on...

Citigroup Has Lowered Expectations for LENZ Therapeutics (NASDAQ:LENZ) Stock Price

Citigroup decreased their price objective on shares of LENZ Therapeutics from $52.00 to $26.00 and set a "buy" rating for the company in a report on Thursday...

FY2028 EPS Forecast for LENZ Therapeutics Lowered by Analyst

LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) - HC Wainwright lowered their FY2028 earnings per share (EPS) estimates for LENZ Therapeutics in a research note issued on Wednesday, March 25th. HC Wainwright analyst M. Caufield now anticipates that the company will earn $0.62 per share for the y...

Bank of America Has Lowered Expectations for LENZ Therapeutics (NASDAQ:LENZ) Stock Price

Bank of America decreased their target price on shares of LENZ Therapeutics from $35.00 to $29.00 and set a "buy" rating on the stock in a research report on Wednesday...

LENZ Therapeutics (NASDAQ:LENZ) Posts Earnings Results, Misses Expectations By $0.25 EPS

LENZ Therapeutics (NASDAQ:LENZ - Get Free Report) posted its earnings results on Tuesday. The company reported ($1.16) EPS for the quarter, missing analysts' consensus estimates of ($0.91) by...

LENZ Therapeutics Q4 Earnings Call Highlights

Executives from LENZ Therapeutics (NASDAQ:LENZ) used the company's latest earnings call to provide an update on the early U.S. launch of its presbyopia eye drop, emphasizing initial physician...

LENZ Therapeutics, Inc. is a pre-commercial biopharmaceutical company, which focuses on the development and commercialization of innovative therapies to improve vision. It offers eye drop product treatment for presbyopia. The company was founded by James W. McCollum in July 2013 and is headquartered in Solana Beach, CA.

Current Price	$9.86
Prev Close	$10.13
Open	$10.32
Dividend Yield	0.00%
50-Day Moving Average	$11.33
Beta	1.49
Avg. Volume	1.17M
PE Ratio	-3.61

52-Week High	$50.40
52-Week Low	$8.25
Market Capitalization	$317.62M
EPS (Annual)	-$2.85
Price to Book	1.12
Revenue Per Employee	$125,578.95

LENZ
LENZ Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LENZ News

LENZLENZ Therapeutics Inc.